Results for
"[search-keyword]"
Sponsor content
811 result(s) found, displaying 81 to 90
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2024
-
Prescription medicine registrationActive ingredients: palbociclib.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BLOOMS ESCITALOPRAM escitalopram (as oxalate) 10 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BLOOMS ESCITALOPRAM escitalopram (as oxalate) 20 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CIPLA DAPTOMYCIN daptomycin 350 mg powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CIPLA DAPTOMYCIN daptomycin 500 mg powder for injection vial.
-
Cancellation by sponsorRequested by Cipla Australia Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PHARMACY HEALTH FEXOFENADINE HAYFEVER & ALLERGY RELIEF fexofenadine hydrochloride 180 mg film coated tablet blister pack (new formulation).
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PRICELINE PHARMACY FEXOFENADINE HAYFEVER & ALLERGY RELIEF fexofenadine hydrochloride 180 mg film coated tablet blister pack (new formulation).
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for METHOTREXATE CIPLA 2.5 methotrexate 2.5 mg tablet blister pack.